This regulatory role of GFPT1 in modulating cell viability and apoptosis suggests that targeting GFPT1 could be a promising therapeutic strategy, particularly in metastatic or chemotherapy-resistant breast cancer. This evidence concerns the gene GFPT1 and breast carcinoma.